To examine whether the effect of fibroblasts on cancer cell death on treatment with chemotherapeutic drugs involved modulation of p53, we exposed LNCaP cells to fibroblasts in co-culture or to fibroblast-conditioned medium and assessed p53 protein levels on treatment with doxorubicin, mitomycin C or taxol. Here, TP53 is linked to cancer.